Research Peptide Dosing Protocols: A Practical Guide

Why Dosing Protocols Matter in Peptide Research

The difference between a well-designed peptide research protocol and a poorly designed one often comes down to dosing — the amount, frequency, timing, and route of administration. Peptides are not like small molecule drugs where a single daily dose is standard. Many peptides have short half-lives requiring multiple daily administrations; others have pulsatile release patterns that must be respected; and some require cycling to prevent receptor desensitization. This guide provides a framework for designing valid peptide research protocols.

Reconstitution: The Foundation

All lyophilized (freeze-dried) peptides must be reconstituted before use. Proper reconstitution is critical for maintaining peptide integrity:

Standard reconstitution protocol:

1. Allow the vial to reach room temperature before opening
2. Use bacteriostatic water (0.9% benzyl alcohol) for multi-use vials
3. Inject the water slowly down the side of the vial — do not inject directly onto the peptide cake
4. Gently swirl (do not shake) until fully dissolved
5. Store reconstituted peptide at 2–8°C
6. Use within 28–30 days of reconstitution

Calculating concentration: If you add 2 mL of bacteriostatic water to a 5 mg vial, the concentration is 2.5 mg/mL (2,500 mcg/mL). A 250 mcg dose would require 0.1 mL (10 units on a 100-unit insulin syringe).

Dosing Protocols by Peptide Class

GH Secretagogues

| Peptide | Research Dose | Frequency | Timing | |---------|--------------|-----------|--------| | Ipamorelin | 200-300 mcg | 2-3x daily | Fasted, pre-sleep | | CJC-1295 no DAC | 100-200 mcg | 2-3x daily | With Ipamorelin | | CJC-1295 w/ DAC | 1-2 mg | Once weekly | Any time | | Sermorelin | 200-500 mcg | Once daily | Pre-sleep | | GHRP-6 | 100-300 mcg | 2-3x daily | Fasted | | MK-677 | 10-25 mg | Once daily | Pre-sleep |

Key principle: GH secretagogues work best when administered in a fasted state (2+ hours after last meal) to avoid somatostatin suppression from elevated insulin. Pre-sleep administration aligns with the natural nocturnal GH pulse.

Tissue Repair Peptides

| Peptide | Research Dose | Frequency | Duration | |---------|--------------|-----------|----------| | BPC-157 | 250-500 mcg | Once or twice daily | 4-12 weeks | | TB-500 | 2-5 mg | 2x weekly (loading), then weekly | 4-6 weeks | | GHK-Cu | 200-400 mcg | Once daily | 4-8 weeks |

Immunomodulatory Peptides

| Peptide | Research Dose | Frequency | Duration | |---------|--------------|-----------|----------| | Thymosin Alpha-1 | 1.6 mg | 2x weekly | 6-12 months | | Selank | 250-500 mcg | 1-3x daily (intranasal) | 2-4 weeks | | Semax | 200-600 mcg | 1-3x daily (intranasal) | 2-4 weeks |

Cycling Protocols

Cycling (periods of use followed by periods of off) is important for several peptide classes:

GH secretagogues: Continuous use can lead to receptor desensitization and reduced GH response. Common research protocols use 5 days on / 2 days off, or 8-12 week cycles with 4-week breaks.

Immunomodulatory peptides: Thymosin Alpha-1 is typically used in defined courses (6-12 months) rather than continuously. Selank and Semax are often used in 2-4 week courses.

Tissue repair peptides: BPC-157 and TB-500 are often used in 4-12 week courses for specific injury protocols, with maintenance dosing as needed.

Injection Technique

Subcutaneous injection: - Use 27-31 gauge, 0.5-inch insulin syringes - Pinch skin at injection site (abdomen, thigh, or upper arm) - Insert needle at 45-degree angle - Inject slowly, release skin, withdraw needle - Rotate injection sites to prevent lipodystrophy

Intranasal administration (Selank, Semax): - Use a nasal spray bottle or dropper - Tilt head slightly back - Administer 2-3 drops per nostril - Sniff gently to distribute solution

Protocol Design Considerations

| Variable | Consideration | |----------|--------------| | Baseline measurements | Establish before starting (IGF-1, hormones, biomarkers) | | Endpoint timing | Allow sufficient time for effects to manifest | | Controls | Include appropriate controls for valid comparison | | Confounding variables | Control diet, exercise, sleep during research period | | Washout period | Allow adequate washout between protocols |

Storage Best Practices

| State | Temperature | Duration | |-------|-------------|----------| | Lyophilized (sealed) | Room temperature | 24+ months | | Lyophilized (sealed) | 2-8°C | 36+ months | | Reconstituted | 2-8°C | 28-30 days | | Reconstituted | -20°C | 3-6 months (avoid repeated freeze-thaw) |

Key Research Takeaways

Proper dosing protocol design is as important as peptide selection for valid research outcomes. Key principles: reconstitute carefully, respect half-life with appropriate dosing frequency, time administration to align with physiological rhythms (fasted state for GH secretagogues, pre-sleep for nocturnal effects), cycle appropriately to prevent desensitization, and establish baseline measurements before starting any protocol.